High MEK signature score is reported [2] to enrich for sensitivity to MEK inhibition in cancer cell lines, low MEK signature score is predictive of resistance, and high “compensatory resistance (Cres)” signature score predictive of resistance in the presence of high MEK signature. Here, MAP2K7 is linked to cancer.